Professor Mordechai Kramer
A world-class pulmonologist, specialist in the treatment of respiratory diseases. Recovery and rehabilitation after COVID-19.
Mordechai Kramer expertly performs invasive diagnostics of bronchopulmonary pathologies as well as highly complex operations according to new standards. In particular, he uses laser therapy, lung reconstruction after removal of tumors, and stenting. Professor Kramer is a world expert in the treatment of lung cancer and provides therapy according to proven international protocols and his own developments.
In addition to active clinical practice, the professor conducts intensive research, with his scientific work devoted to problems of endobronchial therapy. He is the author of more than three hundred articles and studies on the diagnosis and treatment of pulmonary diseases.
Mordechai Kramer was chosen as her attending physician by Nechama Rivlin, First Lady of Israel, and thanks to this doctor she was able to courageously fight for 12 years an almost incurable disease, idiopathic pulmonary fibrosis.
The lung transplant operation for Nechama Rivlin demonstrated the doctor's readiness to fight for the patient's life to the end. For 73-year-old Nechama, whose lung condition was very severe and worsening daily, the operation gave three months of life. The transplant was a shared, risky decision of the doctor, the patient and her family, and the outcome did not change the doctor's determination to give a chance even to the oldest and most seriously ill patients.
Dr. Kramer received his first professional education at Hadassah Ein Kerem University Hospital. He completed his residency at Stanford and in Miami, USA, and trained there in the treatment of pulmonary diseases and lung transplantation.
Today Mordechai Kramer actively practices and passes on his experience to young doctors. He conducts research on improving treatment methods for bronchopulmonary diseases, endobronchial therapy and lung transplantation. He has more than 300 publications in Israeli and international medical journals, including a substantial monograph on transplantation.
Professional memberships
- International Society for Heart and Lung Transplantation (ISHLT);
- American Thoracic Society (ATS);
- American College of Chest Physicians;
- European Respiratory Society (ERS).
- recovery and rehabilitation after COVID-19
- lung cancer;
- asthma;
- pulmonary hypertension;
- pneumonia;
- pulmonary fibrosis;
- silicosis;
- pulmonary lymphangioleiomyomatosis;
- alveolar proteinosis;
- sarcoidosis.